vialroom

#retatrutide 2026-06-12

Friday16 messages4 participantstimes are UTC
Highlights from this day
  • shame_and_meds — unrelated but triple agonist, GLP-1 and GIP and glucagon. the glucagon arm is the part with no long history 18:50
  • pioneer_pia — coming back to this the phase 2 weight result was larger than what the earlier agonists reported, in a smaller shorter trial 18:51
  • patent_2026 — nobody should read my log as a plan, im recording what i did and thats all it is no idea whether the heart rate settles for everyone, mine did and one log isnt data 18:54
  • pioneer_pia — the honest position is this has less human evidence behind it than anything else discussed here 20:37
  • pioneer_pia — anyone compared their VendorInvestigate purity across two different SGN lots 21:52
SA

while im here how do people square the research use only framing with logging their own use

is TRIUMPH the phase 3 programme

SA

unrelated but triple agonist, GLP-1 and GIP and glucagon. the glucagon arm is the part with no long history

PP

coming back to this the phase 2 weight result was larger than what the earlier agonists reported, in a smaller shorter trial

FF

people insist on small steps because the side effects arrive faster than on the other two

SA

the half life supports weekly dosing and thats what ive done from the start

PP

the honest position is this has less human evidence behind it than anything else discussed here

PP

triple agonist meaning GLP-1, GIP and glucagon, have i got that right

anyone compared their VendorInvestigate purity across two different SGN lots